Search results for "beta-Lactam"

showing 10 items of 105 documents

Regional Variation of Extended-Spectrum Beta-Lactamase (ESBL)-Producing Enterobacterales, Fluoroquinolone-Resistant Salmonella enterica and Methicill…

2020

Background: Antimicrobial resistance (AMR) thwarts the curative power of drugs and is a present-time global problem. We present data on antimicrobial susceptibility and resistance determinants of bacteria the WHO has highlighted as being key antimicrobial resistance concerns in Africa, to strengthen knowledge of AMR patterns in the region. Methods: Blood, stool, and urine specimens of febrile patients, aged between ≥ 30 days and ≤ 15 years and hospitalized in Burkina Faso, Gabon, Ghana, and Tanzania were cultured from November 2013 to March 2017 (Patients > 15 years were included in Tanzania). Antimicrobial susceptibility testing was performed for all Enterobacterales and Staphylococcus aur…

Microbiology (medical)sub-Saharan AfricaSalmonellaextended-spectrum beta-lactamase-(ESBL)Klebsiella pneumoniaemedicine.medical_treatmentlcsh:QR1-502Biologymethicillin-resistant Staphylococcus aureusmedicine.disease_causeMicrobiologylcsh:MicrobiologyMicrobiology03 medical and health sciencesAntibiotic resistanceEnterobacteralesparasitic diseasesmedicineantimicrobial resistanceOriginal Research030304 developmental biologyfever0303 health sciences030306 microbiologySalmonella entericabiochemical phenomena metabolism and nutritionbiology.organism_classificationbacterial infections and mycosesMethicillin-resistant Staphylococcus aureusStaphylococcus aureusSalmonella entericaBeta-lactamaseMultilocus sequence typingFrontiers in microbiology
researchProduct

Targeting the Class A Carbapenemase GES-5 via Virtual Screening

2020

The worldwide spread of &beta

Models MolecularDrugantibiotic resistanceGES-5Antibiotic resistancemedia_common.quotation_subjectIn silicoDrug Evaluation Preclinicallcsh:QR1-502Guyana extended-spectrum-β-lactamaseMicrobial Sensitivity TestsComputational biologyBiologyBiochemistrybeta-LactamasesArticlelcsh:Microbiologyguyana extended-spectrum-β-lactamasecarbapenemase03 medical and health sciencesAntibiotic resistanceBacterial ProteinsDrug Resistance BacterialHumansAntibiotic resistance; GES-5; Guyana extended-spectrum-β-lactamase; carbapenemase; virtual screening; docking; noncovalent inhibitionges-5noncovalent inhibitionMolecular Biology030304 developmental biologymedia_common0303 health sciencesVirtual screening030306 microbiologyAntibiotic resistance; Carbapenemase; Docking; GES-5; Guyana extended-spectrum-β-lactamase; Noncovalent inhibition; Virtual screeningHit to leadvirtual screeningAntimicrobialAnti-Bacterial AgentsCarbapenemsdockingBiomolecules
researchProduct

Synthesis of enantiopure pyrrolidine-derived peptidomimetics and oligo-beta-peptides via nucleophilic ring-opening of beta-lactams.

2006

The synthesis of the two enantiomers of pyrrolidine-derived spiro beta-lactams by resolution with D- and L-Boc phenylalanine is described. The potential of these optically active spiro beta-lactams on the synthesis of peptidomimetics as analogues of melanostatin is evaluated. Theoretical studies of several models, at the Becke3LYP/6-31+G* level of theory, together with previous experimental evidences from our group, gathered by NMR, allow us to design structures that can efficiently mimic some biologically active peptide-type molecules. On the other hand, the spiro beta-lactams have shown their utility in the preparation of beta-peptides. As an example, a homo-tetra-beta-peptide was synthes…

Models MolecularMagnetic Resonance SpectroscopyPyrrolidinesPeptidomimeticStereochemistryStereoisomerismRing (chemistry)beta-LactamsChemical synthesisPyrrolidinechemistry.chemical_compoundNucleophileβ lactamschemistry.chemical_classificationOrganic ChemistryMolecular MimicryStereoisomerismNuclear magnetic resonance spectroscopyGeneral MedicineMSH Release-Inhibiting HormoneAmino acidEnantiopure drugchemistryDrug DesignLactamOligopeptidesThe Journal of organic chemistry
researchProduct

Role of Protein Flexibility in Enzymatic Catalysis:  Quantum Mechanical−Molecular Mechanical Study of the Deacylation Reaction in Class A β-Lactamases

2002

We present a theoretical study of a mechanism for the hydrolysis of the acyl-enzyme complex formed by a class A beta-lactamase (TEM1) and an antibiotic (penicillanate), as a part of the process of antibiotic's inactivation by this type of enzymes. In the presented mechanism the carboxylate group of a particular residue (Glu166) activates a water molecule, accepting one of its protons, and afterward transfers this proton directly to the acylated serine residue (Ser70). In our study we employed a quantum mechanics (AM1)-molecular mechanics partition scheme (QM/MM) where all the atoms of the system were allowed to relax. For this purpose we used the GRACE procedure in which part of the system …

Models MolecularProtonAcylationHydrolysisProtonationGeneral Chemistrybeta-LactamsBiochemistryProtein Structure Secondarybeta-LactamasesCatalysisAnti-Bacterial AgentsEnzyme catalysisCatalysisAdductchemistry.chemical_compoundResidue (chemistry)Colloid and Surface ChemistrychemistryComputational chemistryQuantum TheoryThermodynamicsMoleculeCarboxylateJournal of the American Chemical Society
researchProduct

Computational study on hydrolysis of cefotaxime in gas phase and in aqueous solution

2012

We are presenting a theoretical study of the hydrolysis of a β-lactam antibiotic in gas phase and in aqueous solution by means of hybrid quantum mechanics/molecular mechanics potentials. After exploring the potential energy surfaces at semiempirical and density functional theory (DFT) level, potentials of mean force have been computed for the reaction in solution with hybrid PM3/TIP3P calculations and corrections with the B3LYP and M06-2X functionals. Inclusion of the full molecule of the antibiotic, Cefotaxime, in the gas phase molecular model has been demonstrated to be crucial since its carboxylate group can activate a nucleophilic water molecule. Moreover, the flexibility of the substra…

Models MolecularReaction mechanismPopulationCefotaximebeta-Lactamaseschemistry.chemical_compoundComputational chemistryMoleculeCarboxylateeducationConformational isomerismReaction mechanismeducation.field_of_studyAqueous solutionHydrolysisWaterHydrogen BondingGeneral ChemistryAnti-Bacterial AgentsSolutionsKineticsMetallo-beta-lactamasesComputational MathematicsModels ChemicalchemistryIntramolecular forceMβLsQuantum TheoryThermodynamicsDensity functional theoryGasesJournal of Computational Chemistry
researchProduct

Comparative trial between the use of amoxicillin and amoxicillin clavulanate in the removal of third molars

2014

Objectives: The purpose of this study was to compare the use of amoxicillin (1g) vs amoxicillin and clavulanate (875/125mg) after extraction of retained third molars for prevention of infectious complications. Study Design: The study involved 546 patients attending for removal a retained third molar and divided in to two groups: Group 1 - amoxicillin and clavunate (875/125mg) group (n=257) and Group 2 - amoxicillin (1g) group (n=289). All patients were recalled for investigating the possibility of infection, presence of diarrhea and further analgesic intake. Results: From a total of 546 patients, the frequency of infection was 1.4%, without no statistically differences be - tween the two gr…

MolarAdultMalemedicine.medical_specialtyComplicationsAnalgesicOdontologíaAmoxicillin-Potassium Clavulanate CombinationGastroenterologylaw.inventionPostoperative ComplicationsRandomized controlled triallawInternal medicinemedicineHumansGeneral DentistryBeta-Lactamase InhibitorsAMOXICILLIN/CLAVULANATEbusiness.industryResearchAmoxicillinBacterial InfectionsAmoxicillin:CIENCIAS MÉDICAS [UNESCO]Ciencias de la saludSurgeryAnti-Bacterial AgentsThird molarsDiarrheaOtorhinolaryngologyClavulanateUNESCO::CIENCIAS MÉDICASTooth ExtractionSurgeryFemaleMolar ThirdAmoxicillin-Potassium Clavulanate Combinationmedicine.symptomOral Surgerybusinessbeta-Lactamase Inhibitorsmedicine.drugMedicina Oral, Patología Oral y Cirugía Bucal
researchProduct

Asymmetric Synthesis of Spirocyclic β-Lactams through Copper-Catalyzed Kinugasa/Michael Domino Reactions

2018

The first copper-catalyzed highly chemo-, regio-, diastereo-, and enantioselective Kinugasa/Michael domino reaction for the desymmetrization of prochiral cyclohexadienones is described. In the presence of a chiral copper catalyst, alkyne-tethered cyclohexadienones couple with nitrones to generate the chiral spirocyclic lactams with excellent stereoselectivity (up to 97 % ee, >20:1 dr). The new method provides direct access to versatile highly functionalized spirocyclic β-lactams possessing four contiguous stereocenters, including one quaternary and one tetra-substituted stereocenter.

Molecular Structure010405 organic chemistryStereochemistryChemistryasymmetric synthesisEnantioselective synthesisGeneral MedicineGeneral Chemistrybeta-Lactams010402 general chemistry01 natural sciencesDesymmetrizationCatalysisDomino0104 chemical sciencesCatalysisStereocenterCascade reactionAlkynesβ lactamsStereoselectivityta116CopperAngewandte Chemie International Edition
researchProduct

Antimicrobial de-escalation in the critically ill patient and assessment of clinical cure : the DIANA study

2020

© 2020 The Author(s).

OriginalDELPHI METHODCritical Care and Intensive Care MedicineGUIDELINESlaw.invention0302 clinical medicineAnti-Infective Agents[SDV.MHEP.MI]Life Sciences [q-bio]/Human health and pathology/Infectious diseaseslawEpidemiologyMedicine and Health SciencesAntimicrobial de-escalationEPIDEMIOLOGYComputingMilieux_MISCELLANEOUS[SDV.MHEP.ME]Life Sciences [q-bio]/Human health and pathology/Emerging diseasesVentilator-associated pneumoniaIntensive care unitAnti-Bacterial Agents3. Good healthIntensive Care UnitsSTEWARDSHIP PROGRAM[SDV.MP.VIR]Life Sciences [q-bio]/Microbiology and Parasitology/VirologyCohortAntimicrobial de-escalation; Bacterial infection; Clinical cure; Empirical therapy; Intensive care unit;Clinical cureAntimicrobial de-escalation; Bacterial infection; Clinical cure; Empirical therapy; Intensive care unitAdultmedicine.medical_specialtyCombination therapyCritical IllnessANTIBIOTIC-THERAPYNO03 medical and health sciences[SDV.MHEP.CSC]Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular systemBETA-LACTAMInternal medicineSettore MED/41 - ANESTESIOLOGIAmedicineHumans[SDV.MP.PAR]Life Sciences [q-bio]/Microbiology and Parasitology/ParasitologyIntensive care unitVENTILATOR-ASSOCIATED PNEUMONIAbusiness.industrySEPTIC SHOCKR-PACKAGEbacterial infectionIntensive care unit.030208 emergency & critical care medicinemedicine.disease[SDV.MP.BAC]Life Sciences [q-bio]/Microbiology and Parasitology/BacteriologyEmpirical therapyDiscontinuationSEVERE SEPSISlnfectious Diseases and Global Health Radboud Institute for Health Sciences [Radboudumc 4]Carbapenems030228 respiratory systemRelative riskBacterial infectionbusinessDe-escalation
researchProduct

An international perspective on hospitalized patients with viral community-acquired pneumonia

2019

Background Who should be tested for viruses in patients with community acquired pneumonia (CAP), prevalence and risk factors for viral CAP are still debated. We evaluated the frequency of viral testing, virus prevalence, risk factors and treatment coverage with oseltamivir in patients admitted for CAP. Methods Secondary analysis of GLIMP, an international, multicenter, point-prevalence study of hospitalized adults with CAP. Testing frequency, prevalence of viral CAP and treatment with oseltamivir were assessed among patients who underwent a viral swab. Univariate and multivariate analysis was used to evaluate risk factors. Results 553 (14.9%) patients with CAP underwent nasal swab. Viral CA…

PNEUMONIAMaleMultivariate analysisInternationalityPCV13 pneumococcal conjugate vaccineDatabases FactualHospitalized patientsmedicine.medical_treatmentvirusesCAD coronary artery diseaseTesting030204 cardiovascular system & hematologyMRSA methicillin resistant Staphylococcus aureusPneumònia adquirida a la comunitatRT-PCR reverse transcriptase polymerase chain reactionchemistry.chemical_compound0302 clinical medicineCommunity-acquired pneumoniaTaverne80 and overCommunity-Acquired InfectionViral030212 general & internal medicineProspective StudiesAged 80 and overRIDT rapid influenza diagnostic testCAP community-acquired pneumoniaRSV Respiratory Syncytial virusMiddle AgedICU intensive care unitCommunity-Acquired InfectionsHospitalizationNasal SwabInfectious diseasesFemaleViral swabHumanOseltamivirmedicine.medical_specialtyLogistic ModelCommunity-acquired pneumoniaViral pneumoniaCommunity acquired pneumonia; Influenza; Oseltamivir; Testing; Viral pneumonia; Viral swab; Aged; Aged 80 and over; Antiviral Agents; Community-Acquired Infections; Cross-Sectional Studies; Databases Factual; Female; Hospitalization; Humans; Influenza Human; Internationality; Logistic Models; Male; Medication Adherence; Middle Aged; Oseltamivir; Pneumonia Viral; Prospective StudiesPneumonia ViralAdmissionSettore MED/10 - Malattie Dell'Apparato RespiratorioInfluenzavirusAntiviral AgentsVirusArticleMedication AdherenceHMPV human MetapneumovirusDatabases03 medical and health sciencesLRTI lower respiratory tract infectionOseltamivirInternal medicineInfluenza HumanInternal MedicinemedicineInfluenza virusesHumansHIV Human Immunodeficiency virusPPSV23 pneumococcal polysaccharide vaccineIn patientFactualAgedMechanical ventilationAntiviral AgentCross-Sectional Studiebusiness.industryFEV1 forced expiratory volume in one secondGLIMP global initiative for methicillin-resistant Staphylococcus aureus pneumoniaESBL extended-spectrum beta-lactamasesPneumoniamedicine.diseaseInfluenzaCommunity acquired pneumoniaCI confidence intervalOR odds ratioCross-Sectional StudiesLogistic ModelschemistryCOPD chronic obstructive pulmonary diseasebusinessCommunity acquired pneumonia ; Influenza ; Oseltamivir ; Testing ; Viral pneumonia ; Viral swab
researchProduct

Should continuous infusion of β‐lactam antibiotics be the first‐line approach?

1997

PharmacologyContinuous infusionbusiness.industryStaphylococcusFirst lineStreptococcusMicrobial Sensitivity TestsPharmacologyGram-Positive Bacteriabeta-LactamsAnti-Bacterial AgentsDrug Delivery SystemsInjections IntravenousAnimalsHumansMedicinePharmacology (medical)Infusions IntravenousbusinessEnterococcusGram-Positive Bacterial InfectionsBeta lactam antibioticsJournal of Clinical Pharmacy and Therapeutics
researchProduct